ISRCTN29941643已完成未知
ational randomised trial of hormone replacement therapy (HRT) in women with a history of early stage breast cancer
Individual Sponsor (UK)0 个研究点目标入组 3,000 人开始时间: 2001年7月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 3,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •1. Patients must have had proven stage I/II breast cancer with no clinical evidence of recurrence since diagnosis
- •2. Have been given a patient information pack
- •3. Be postmenopausal as defined by:
- •a. Having been amenorrhoeic for at least 6 months (including women who have had radiation or chemical induced ovarian suppression) irrespective of menopausal status at time of diagnosis
- •b. Having received surgical bilateral oophorectomy
- •c. Be experiencing vasomotor symptoms (i.e. hot flushes or night sweats) with or without vaginal dryness.
- •All such women are eligible irrespective of current/previous treatment for breast cancer.
排除标准
- •Not provided at time of registration
研究者
相似试验
已完成
不适用
The PROOF trial: PROtecting Ovaries and Fertility during chemotherapyISRCTN96797814Ottawa Hospital Research Institute (OHRI) (Canada) - formerly Ottawa Health Research Institute30
撤回
4 期
Pregnancy outcomes when adding a progesterone pessary dose amongst women who are receiving frozen embryo transfer with hormone replacement therapy, compared with placebo.Reproductive Health and Childbirth - Fertility including in vitro fertilisationInfertilityACTRN12617001016325Monash IVF Pty Ltd304
招募中
不适用
Clinical trial of testosterone replacement therapy for the male hypogonadotropic hypogonadism with pituitary or hypothalamic tumor.JPRN-UMIN000033962Department of Metabolic Medicine. Osaka University Graduate School of Medicine30
已完成
不适用
The Effect of Low Dose Hormone Replacement Therapy or Raloxifene on Bone and Lipid Metabolism in Hemodialysis PatientsPostmenopausal osteopenia in hemodialysis patientsJPRN-C000000390Department of Nephrology, Osaka University School of Medicine39
进行中（未招募）
不适用
Phase I/II clinical trial:Immunotherapy of hormone-refractory prostate cancer patients with dendritic cell-based vaccine (Fáze I/II klinické studie imunoterapie hormonálne refrakterního karcinomu prostaty pomocí vakcinace dendritickými bunkami) - Imunoterapie karcinomu prostaty dendritickými bunkamiPatients with hormone-refractory prostate cancerEUCTR2009-017295-24-CZniversity Hospital Motol